Work

Targeting the β secretase BACE1 for Alzheimer's disease therapy

Year: 2014

Type: review

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(13)70276-x

Authors: Riqiang Yan, Robert Vassar

Institutions: Cleveland Clinic, Cleveland Clinic Research, Northwestern University

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, Eisai, National Institute on Aging, National Institute of Neurological Disorders and Stroke

Awards: Roles of reticulon proteins in neurodegenerative disorders, BACE1 as a Therapeutic Target for Alzheimer's Disease, Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease, BACE1 as a Therapeutic Target for Alzheimer's Disease, BACE1 in neurodegeneration and neurological dysfunction

OpenAlex ID: W2041573170

FWCI: 6.781

Cites: 85

Cited by: 649

Related to: 10